Trusted News Discovery Since 2008
{{/content}}
US allows emergency use of antiviral drug remdesivir to treat Covid-19 patients
Video Credit: HT Digital Content
Published on May 2, 2020 - Duration: 02:47s
US allows emergency use of antiviral drug remdesivir to treat Covid-19 patients
The US has allowed the emergency use of the experimental antiviral drug remdesivir to treat Covid-19 based on early clinical data that shows it helps coronavirus disease patients recover faster.
The antiviral drug remdesivir is made by Gilead Sciences and is the world’s first drug approved based on clinical data to treat Covid-19, which has killed close to 240,000 people worldwide.
Emergency-use authorization allows products to be used for treatment without full data on their safety and efficacy, which has to be still submitted as trial continue.
You are here
Related news from verified sources
The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to...
on May 1, 2020 • Reuters India
The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to...
on May 1, 2020 • Reuters India
Japan will fast-track a review of Gilead Sciences Inc's antiviral drug remdesivir so that it can hopefully be approved for domestic COVID-19 patients a week...
on May 2, 2020 • Reuters India
Related videos from verified sources
SD company starts clinical trial for drug that could help prevent use of ventilators for COVID-19 patients 02:04
Video credit: ABC 10 News | San Diego - Published on May 29, 2020
France Becomes the First Country to Ban Hydroxychloroquine as a Treatment for COVID-19 00:44
Video credit: Veuer - Published on May 27, 2020
Matt Hancock announces new anti-viral drug trial 02:11
Video credit: ODN - Published on May 26, 2020